August 22, 2025

KalVista Pharmaceuticals (KALV) Investor Outlook: Exploring a 144% Potential Upside in the Biotech Sector

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a burgeoning player in the biotechnology industry, is grabbing investor attention with its ambitious pipeline and striking analyst ratings. Headquartered in..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: A 29% Upside Potential with Growing Revenue

For investors with an eye on the healthcare sector, Avadel Pharmaceuticals plc (NASDAQ: AVDL) presents an intriguing opportunity worth examining. Based in Ireland, this biopharmaceutical company..

Weave Communications, Inc. (WEAV) Stock Analysis: A 60% Upside Potential in the Healthcare Tech Sector

For investors looking into the dynamic intersection of healthcare and technology, Weave Communications, Inc. (NASDAQ: WEAV) presents an intriguing opportunity. As of the latest data, this..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 262.90% Potential Upside for Investors

Kura Oncology, Inc. (NASDAQ: KURA) is making waves in the biotechnology sector with its impressive focus on cancer treatment innovations. The San Diego-based clinical-stage biopharmaceutical company..

SI-BONE, Inc. (SIBN) Stock Analysis: A 59.85% Potential Upside Sparks Investor Interest

SI-BONE, Inc. (NASDAQ: SIBN), a key player in the medical devices sector, is making waves with its innovative solutions aimed at tackling musculoskeletal disorders of the..

uniQure N.V. (QURE) Stock Report: Exploring a 123.60% Potential Upside in the Biotech Sector

uniQure N.V. (NASDAQ: QURE), a prominent player in the biotechnology sector, has caught the attention of investors with its significant potential upside of 123.60%, according to..

GH Research PLC (GHRS) Stock Analysis: A Biotech with 152.67% Potential Upside

GH Research PLC (NASDAQ: GHRS) has captured the attention of investors with its promising potential upside of 152.67%. This Dublin-based biotechnology firm, specializing in innovative treatments..

Regulus Therapeutics Inc. (RGLS) Investor Outlook: What the -14.22% Potential Downside Means for Shareholders

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biotechnology firm focused on developing innovative therapies to combat genetically based orphan diseases. Headquartered in San Diego, California, the..

Talkspace, Inc. (TALK) Stock Analysis: Breaking Down the 76% Potential Upside

Talkspace, Inc. (NASDAQ: TALK), a prominent player in the digital mental health space, offers a compelling case for investors seeking exposure to the burgeoning healthcare technology..

AMN Healthcare Services Inc (AMN) Stock Analysis: Evaluating the 3.24% Potential Upside Amidst Sector Challenges

AMN Healthcare Services Inc (NYSE: AMN), a prominent name in the healthcare sector, is catching the eye of investors with a potential upside of 3.24%. Despite..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: A 72.59% Potential Upside Sparks Investor Interest

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a healthcare company based in San Diego, California, specializing in biotechnology. With a market cap of $874.85 million, Maravai..

Delcath Systems, Inc. (DCTH) Stock Analysis: A 133% Potential Upside and Strong Buy Ratings in the Medical Device Sector

Delcath Systems, Inc. (NASDAQ: DCTH) is drawing significant attention in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $364.16 million,..

Nurix Therapeutics (NRIX) Stock Analysis: Unveiling a 209% Potential Upside in Biotech

Nurix Therapeutics, Inc. (NRIX), a burgeoning player in the biotechnology industry, presents a compelling case for investors eyeing high-growth opportunities in the healthcare sector. Based in..

Vir Biotechnology, Inc. (VIR) Stock Analysis: A Look at the 302% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, has captured the attention of investors with an eye-popping potential upside of 302.40%. With a market capitalization..

Immunome, Inc. (IMNM) Stock Analysis: A Biotech Bet with 143% Upside Potential

Immunome, Inc. (NASDAQ: IMNM) is making waves in the biotechnology sector, offering exciting prospects for investors looking to capitalize on its burgeoning pipeline of cancer therapies...

InnovAge Holding Corp. (INNV) Stock Analysis: A 44.93% Potential Upside Despite Challenges

InnovAge Holding Corp. (NASDAQ: INNV) stands out in the healthcare sector as a unique player focusing on the needs of seniors through its PACE (Program of..

Neuropace, Inc. (NPCE) Stock Analysis: A Look at the 94% Potential Upside for Investors

Neuropace, Inc. (NASDAQ: NPCE) is capturing attention in the healthcare sector, particularly within the medical devices industry, as its innovative solutions target a critical unmet need..

Niagen Bioscience, Inc. (NAGE): Biotech Stock with a 64% Upside Potential

Investors with an eye on the healthcare sector may find Niagen Bioscience, Inc. (NASDAQ: NAGE) a compelling opportunity. With a market capitalization of $779.19 million and..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a Potential 110% Upside in Biotechnology

For individual investors with an appetite for high-risk, high-reward stocks, Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) offers a tantalizing opportunity. With a potential upside of over 110%,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Growth Amidst Potential Challenges

Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector, primarily focuses on the production and distribution of animal health and mineral nutrition..

Search

Funds

August 22, 2025

Search

Funds

August 22, 2025

FTSE 100

Funds